Lexaria Bioscience Corp. (LEXX)
0.6056
+0.02
(+4.14%)
USD |
NASDAQ |
May 21, 16:00
Lexaria Bioscience Cash from Investing (Quarterly) : -0.0539M for Feb. 28, 2026
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| CannaPharmaRx, Inc. | 0.00 |
| InMed Pharmaceuticals, Inc. | 0.00 |
| Target Group, Inc. (Canada) | -0.0401M |
| Tilray Brands, Inc. | 28.63M |
| NervGen Pharma Corp. | 0.0061M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -2.164M |
| Cash from Financing (Quarterly) | 3.044M |
| Free Cash Flow | -9.470M |
| Free Cash Flow Per Share (Quarterly) | -0.0908 |
| Free Cash Flow to Equity (Quarterly) | -2.212M |
| Free Cash Flow to Firm (Quarterly) | -2.220M |
| Free Cash Flow Yield | -74.75% |